Your browser doesn't support javascript.
loading
Exosomal Transport of Hepatocyte-Derived Drug-Modified Proteins to the Immune System.
Ogese, Monday O; Jenkins, Rosalind E; Adair, Kareena; Tailor, Arun; Meng, Xiaoli; Faulkner, Lee; Enyindah, Bright O; Schofield, Amy; Diaz-Nieto, Rafael; Ressel, Lorenzo; Eagle, Gina L; Kitteringham, Neil R; Goldring, Chris E; Park, B Kevin; Naisbitt, Dean J; Betts, Catherine.
Afiliación
  • Ogese MO; New Modality Safety, Clinical Pharmacology and Safety Sciences, R&D Biopharmaceuticals, AstraZeneca, Cambridge, United Kingdom.
  • Jenkins RE; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Adair K; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Tailor A; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Meng X; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Faulkner L; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Enyindah BO; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Schofield A; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Diaz-Nieto R; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Ressel L; North Western Hepatobiliary Unit, Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom.
  • Eagle GL; Department of Veterinary Pathology and Public Health, Institute of Veterinary Science, University of Liverpool, Leahurst Campus, Neston, United Kingdom.
  • Kitteringham NR; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Goldring CE; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Park BK; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Naisbitt DJ; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Betts C; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
Hepatology ; 70(5): 1732-1749, 2019 11.
Article en En | MEDLINE | ID: mdl-31070244
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Dendríticas / Hepatocitos / Transporte de Proteínas / Exosomas / Sistema Inmunológico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hepatology Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Dendríticas / Hepatocitos / Transporte de Proteínas / Exosomas / Sistema Inmunológico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Hepatology Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido